New biostimulant seed treatment set to boost wheat yields with reduced fertilizer use
Syngenta Crop Protection partners with Aphea.Bio to bring novel agricultural technology to markets across Europe
Basel, Switzerland/Gent, Belgium, March 1, 2023 - Wheat farmers seeking to increase yields while reducing fertilizer inputs are set to benefit from a new collaboration between Syngenta Crop Protection and Aphea.Bio announced today.
The collaboration aims to accelerate the introduction of a novel biological seed treatment solution across multiple countries in Europe over the next five years, pending regulatory approval. This places a much-needed technology in the hands of farmers seeking to improve the sustainability of their farming operations, and to address challenges arising from an increasingly constrained toolbox of available agricultural technologies as well as evolving consumer demands.
ΛCTIV by Aphea.Bio® is a biostimulant applied as a seed treatment on wheat that is based on beneficial microorganisms. By improving the crop's nutrient use efficiency, it enables as much as five percent higher yields even with reduced fertilizer use.
“We are excited to announce this collaboration with Aphea.Bio, which supports our important ambition of helping feed ever growing populations in more sustainable ways,” said Jonathan Brown, Head of Global Seedcare at Syngenta Crop Protection. “It demonstrates our commitment to bringing novel, nutrient use efficiency solutions to growers, helping safeguard yields if nitrogen inputs are reduced. Combined with our leading conventional seed treatment portfolio, ΛCTIV by Aphea.Bio® will offer a unique value proposition in a fast-changing EU landscape.”
Isabel Vercauteren, CEO and co-founder of Aphea.Bio, said: “We are excited to launch our first wheat biostimulant in partnership with Syngenta. We are joining forces to build a more sustainable and profitable future for European farmers. And this is just the beginning.”
An introduction of ΛCTIV by Aphea.Bio® will represent an additional building block in the strategy to achieving healthy soils by supporting crops through beneficial microorganisms. It furthermore has the potential to contribute to the goal of the European Union's Green Deal to reduce the use of synthetic fertilizers inputs.
About ΛCTIV by Aphea.Bio®:
ΛCTIV by Aphea.Bio® is an innovative and safe biostimulant containing a proprietary bacterial strain of the species Stenotrophomonas rhizophila, which through several modes of action contributes to better growth of wheat plants treated with the product. The strain possesses multiple characteristics involved in adhesion, biofilm production, motility, chemotaxis, uptake and transport of nutrients from the plant, enabling it to successfully colonize the root endosphere. Furthermore, the strain has the potential for inorganic P solubilization and the production of siderophores to enhance the plant update of iron through chelation.
Syngenta is one of the world's leading agriculture companies, comprised of Syngenta Crop Protection and Syngenta Seeds. Our ambition is to help safely feed the world while taking care of the planet. We aim to improve the sustainability, quality and safety of agriculture with world class science and innovative crop solutions. Our technologies enable millions of farmers around the world to make better use of limited agricultural resources. Syngenta Crop Protection and Syngenta Seeds are part of Syngenta Group. In more than 100 countries we are working to transform how crops are grown. Through partnerships, collaboration and The Good Growth Plan we are committed to accelerating innovation for farmers and nature, striving for regenerative agriculture, helping people stay safe and healthy and partnering for impact. To learn more visit www.syngenta.com and www.goodgrowthplan.com.
Follow us on Twitter at www.twitter.com/Syngenta, www.twitter.com/SyngentaUS and on LinkedIn at www.linkedin.com/company/syngenta
Aphea.Bio was founded by Isabel Vercauteren (now CEO of Aphea.Bio) and Steven Vandenabeele (now CTO of Aphea.Bio) on 5 December 2016 as a spin-off of the VIB (Flemish Institute for Biotechnology) and its partner universities Ghent University and KU Leuven, and is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel, science-based solutions to build the agriculture of the future: sustainable, reliable and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput R&D platform utilizing the untapped microbial space, we have been able to build a broad biostimulant and biocontrol pipeline based on naturally occurring micro-organisms.
We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications. To learn more, visit www.aphea.bio or follow us on LinkedIn at www.linkedin.com/company/aphea-bio.
Syngenta Crop Protection
Global Head, External Communications
Head of Regulatory Affairs | Communications
Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR (“legitimate interest”). However, if you do not wish to receive further information about Aphea.Bio, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.
Cautionary Statement Regarding Forward-Looking Statements
This document may contain forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Aphea.Bio, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Aphea.Bio assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
© Aphea.Bio, Technologiepark Zwijnaarde 21, 9052 Zwijnaarde.